Charles River Laboratories International Inc (CRL) is now in the Undervalued zone, suggesting that its current forward PE ratio of 19.20 is considered Undervalued compared with the five-year average of 22.29. The fair price of Charles River Laboratories International Inc (CRL) is between 182.10 to 282.81 according to relative valuation method. Compared to the current price of 178.61 USD , Charles River Laboratories International Inc By Undervalued By 1.92%.

Relative Value

Fair Zone

182.10-282.81

Current Price：178.61

1.92%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Charles River Laboratories International Inc (CRL) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Charles River Laboratories International Inc (CRL) has a current Price-to-Book (P/B) ratio of 2.93. Compared to its 3-year average P/B ratio of 2.85, the current P/B ratio is approximately 2.69% higher. Relative to its 5-year average P/B ratio of 4.22, the current P/B ratio is about -30.63% higher. Charles River Laboratories International Inc (CRL) has a Forward Free Cash Flow (FCF) yield of approximately 5.46%. Compared to its 3-year average FCF yield of 4.81%, the current FCF yield is approximately 13.55% lower. Relative to its 5-year average FCF yield of 3.97%, the current FCF yield is about 37.58% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CRL competitors is 1.73, providing a benchmark for relative valuation. Charles River Laboratories International Inc Corp (CRL.N) exhibits a P/S ratio of 2.47, which is 42.21% above the industry average. Given its robust revenue growth of -0.83%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CRL increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CRL in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CRL currently overvalued or undervalued?

Charles River Laboratories International Inc (CRL) is now in the Undervalued zone, suggesting that its current forward PE ratio of 19.20 is considered Undervalued compared with the five-year average of 22.29. The fair price of Charles River Laboratories International Inc (CRL) is between 182.10 to 282.81 according to relative valuation method. Compared to the current price of 178.61 USD, Charles River Laboratories International Inc is Undervalued By 1.92%.

What is Charles River Laboratories International Inc (CRL) fair value?

CRL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Charles River Laboratories International Inc (CRL) is between 182.10 to 282.81 according to relative valuation method.

How does CRL's valuation metrics compare to the industry average?

The average P/S ratio for CRL's competitors is 1.73, providing a benchmark for relative valuation. Charles River Laboratories International Inc Corp (CRL) exhibits a P/S ratio of 2.47, which is 42.21% above the industry average. Given its robust revenue growth of -0.83%, this premium appears unsustainable.

What is the current P/B ratio for Charles River Laboratories International Inc (CRL) as of Mar 02 2026?

As of Mar 02 2026, Charles River Laboratories International Inc (CRL) has a P/B ratio of 2.93. This indicates that the market values CRL at 2.93 times its book value.

What is the current FCF Yield for Charles River Laboratories International Inc (CRL) as of Mar 02 2026?

As of Mar 02 2026, Charles River Laboratories International Inc (CRL) has a FCF Yield of 5.46%. This means that for every dollar of Charles River Laboratories International Inc's market capitalization, the company generates 5.46 cents in free cash flow.

What is the current Forward P/E ratio for Charles River Laboratories International Inc (CRL) as of Mar 02 2026?

As of Mar 02 2026, Charles River Laboratories International Inc (CRL) has a Forward P/E ratio of 19.20. This means the market is willing to pay $19.20 for every dollar of Charles River Laboratories International Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Charles River Laboratories International Inc (CRL) as of Mar 02 2026?

As of Mar 02 2026, Charles River Laboratories International Inc (CRL) has a Forward P/S ratio of 2.47. This means the market is valuing CRL at $2.47 for every dollar of expected revenue over the next 12 months.

CRL Valuation